Alpha Teknova, Inc. (NASDAQ:TKNO) Short Interest Up 83.3% in January

Alpha Teknova, Inc. (NASDAQ:TKNO) was the target of a significant increase in short interest in January. As of January 15th, there was short interest totalling 644,600 shares, an increase of 83.3% from the December 31st total of 351,600 shares. Approximately 6.1% of the shares of the stock are short sold. Based on an average daily volume of 273,500 shares, the days-to-cover ratio is presently 2.4 days.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. China Universal Asset Management Co. Ltd. purchased a new stake in shares of Alpha Teknova in the 4th quarter valued at about $94,000. Whalen Wealth Management Inc. bought a new stake in shares of Alpha Teknova during the fourth quarter valued at approximately $240,000. State Street Corp boosted its position in shares of Alpha Teknova by 249.3% during the third quarter. State Street Corp now owns 76,645 shares of the company’s stock valued at $371,000 after purchasing an additional 54,700 shares in the last quarter. Nkcfo LLC purchased a new position in Alpha Teknova during the fourth quarter valued at $501,000. Finally, Geode Capital Management LLC raised its stake in Alpha Teknova by 24.4% during the third quarter. Geode Capital Management LLC now owns 188,173 shares of the company’s stock valued at $911,000 after buying an additional 36,914 shares during the last quarter. Institutional investors own 13.81% of the company’s stock.

Alpha Teknova Price Performance

NASDAQ TKNO traded down $0.66 during trading on Friday, hitting $8.84. 201,120 shares of the company’s stock were exchanged, compared to its average volume of 230,146. The company has a current ratio of 4.73, a quick ratio of 3.94 and a debt-to-equity ratio of 0.12. Alpha Teknova has a fifty-two week low of $1.15 and a fifty-two week high of $10.37. The stock’s 50 day moving average price is $8.20 and its two-hundred day moving average price is $6.10. The company has a market cap of $471.24 million, a PE ratio of -11.95 and a beta of 0.34.

Alpha Teknova (NASDAQ:TKNO) last released its quarterly earnings results on Thursday, November 7th. The company reported ($0.15) EPS for the quarter, missing analysts’ consensus estimates of ($0.11) by ($0.04). The company had revenue of $9.58 million during the quarter, compared to analysts’ expectations of $9.30 million. Alpha Teknova had a negative net margin of 87.17% and a negative return on equity of 35.30%. During the same period in the previous year, the company posted ($0.34) earnings per share. Research analysts expect that Alpha Teknova will post -0.58 EPS for the current year.

Alpha Teknova Company Profile

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.